IMCAS ASIA 2023
Cellenis @ IMCAS ASIA 2023 Our cellenis team will be attending the exciting Aesthetic & Dermatology congress taking place from June 9 – 11 at the Athenee Hotel, Bangkok.We are looking forward to meeting everyone there. Be sure to stop by the Cellenis Booth #N70 to meet with our team and to learn more about the Cellenis […]
EFORT 2023
Tropocells at EFORT 2023 Discover the TROPOCELLS OrthoBiologics portfolio @ EFORT 2023. Meet us at the 24th European Federation of National Associations of Orthopedics and Traumatology Congress in Vienna, Austria from May 24-26, 2023.Mark your calendars now for the #Tropocells PRP and #TropoVisc presentations and stop by our booth #B3.1 to learn more about the exciting natural cell therapy […]
AAOS 2023
Tropocells® at AAOS 2023 Tropcells® PRP line of products will be presented and showcased at the Annual Meeting of the American Academy of Orthopedic Surgeons (AAOS) in Las Vegas, Nevada between March 8th-10th 2023. The unique Tropocells® Cell Therapy products, including the reputable Tropocells® PRP & PRF technologies utilize a patented separator gel technology designated to isolate the platelets […]
AMWC 2023
You are welcome to visit us at booth #F4 and meet the Cellenis® European team at AMWC 2023. We will be happy to present and share our latest technologies and innovations, including the Cellenis PRP and the Cellenis DermaFiller, showcase our product specialists and provide the opportunity to deepen your knowledge in the field of […]
IMCAS World Congress 2023
You are welcome to visit us at booth #N152 and meet the Cellenis® PRP European team at the IMCAS World Congress 2023. We will be happy to present and share our latest technologies and innovations, , including the Cellenis DermaFiller, showcase our product specialists and provide the opportunity to deepen your knowledge in the field […]
Regenlab is in Breach of UK Court Orders Following Revocation of its PRP Patent
Regen Lab SA (Regenlab) has failed to pay legal costs ordered by the UK High Court after revocation of its PRP patent for lack of novelty and inventive step. Regenlab is exposed to enforcement procedures which may limit its ability to provide products in the marketplace…
European Patent Office revoked Regenlab PRP patent
Estar Medical has been successful in revoking Regenlab’s original PRP patent in the European Patent Office (EPO) opposition proceedings. This ruling follows a recent judgment by the UK High Court which also found the Regenlab PRP patent invalid for lack of novelty and inventive step…
UK High Court Refuses to Grant Regen Lab Permission to Appeal the PRP Patent Revocation Judgement
The UK Court refused to grant Regenlab permission to appeal the finding that its European PRP patent is invalid…